{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:32:02Z","timestamp":1762540322911},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1016\/s0306-9877(02)00205-0","type":"journal-article","created":{"date-parts":[[2002,10,9]],"date-time":"2002-10-09T12:13:57Z","timestamp":1034165637000},"page":"227-232","source":"Crossref","is-referenced-by-count":21,"title":["In randomized controlled trials, should subjects in both placebo and drug groups be expected to guess that they are taking drug 50% of the time?"],"prefix":"10.1016","volume":"59","author":[{"given":"N.A","family":"Desbiens","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0306-9877(02)00205-0_BIB1","series-title":"The Powerful Pacebo","first-page":"137","article-title":"The history of the double-blind procedure","author":"Shapiro","year":"1997"},{"key":"10.1016\/S0306-9877(02)00205-0_BIB2","series-title":"The Placebo Effect\u2014An Interdisciplinary Exploration","first-page":"37","article-title":"Clinical reflections on the placebo phenomenon","author":"Spiro","year":"1997"},{"key":"10.1016\/S0306-9877(02)00205-0_BIB3","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0021-9681(87)90187-1","article-title":"The problems of taste in placebo matching: an evaluation of zinc gluconate for the common cold","volume":"40","author":"Fair","year":"1987","journal-title":"J. Chronic Dis."},{"key":"10.1016\/S0306-9877(02)00205-0_BIB4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1017\/S0033291700007248","article-title":"Double-blind procedure: an assessment in a study of lithium prophylaxis","volume":"5","author":"Stallone","year":"1975","journal-title":"Psychol. Med."},{"key":"10.1016\/S0306-9877(02)00205-0_BIB5","first-page":"55","article-title":"Physiological performance following a hypnotic dose of a barbiturate","volume":"102","author":"Goodnow","year":"1951","journal-title":"J. Pharm. Exper. Ther."},{"key":"10.1016\/S0306-9877(02)00205-0_BIB6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0306-9877(86)90001-0","article-title":"Double blind: double talk or are there ways to do better research","volume":"21","author":"Ney","year":"1986","journal-title":"Med. Hypotheses"},{"key":"10.1016\/S0306-9877(02)00205-0_BIB7","first-page":"39","article-title":"Placebo effect and placebo concept: a critical methodological an conceptual analysis of reports on the magnitude of the placebo effect","volume":"2","author":"Kienle","year":"1996","journal-title":"Altern. Ther. Health Med."},{"key":"10.1016\/S0306-9877(02)00205-0_BIB8","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/S0140-6736(97)10111-8","article-title":"Powerful placebo: the dark side of the randomised controlled trial","volume":"351","author":"Kaptchuk","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0306-9877(02)00205-0_BIB9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2466\/pms.1979.49.2.367","article-title":"Classification of placebo drugs: effect of color","volume":"49","author":"Jacobs","year":"1979","journal-title":"Percept. Mot. Skills"},{"key":"10.1016\/S0306-9877(02)00205-0_BIB10","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1176\/ajp.139.11.1487","article-title":"The double-blind in danger: untoward consequences of informed consent","volume":"139","author":"Brownell","year":"1982","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/S0306-9877(02)00205-0_BIB11","series-title":"The Powerful Placebo","first-page":"190","article-title":"How blind is blind?","author":"Shapiro","year":"1997"},{"key":"10.1016\/S0306-9877(02)00205-0_BIB12","series-title":"Clinical Decision Making\u2014From Theory To Practice","first-page":"297","article-title":"Clinical policies and the quality of clinical practice","author":"Eddy","year":"1996"},{"key":"10.1016\/S0306-9877(02)00205-0_BIB13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0306-9877(02)00205-0_BIB14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.7326\/0003-4819-133-4-200008150-00016","article-title":"Lessons learned in attempts to establish the blind in placebo-controlled trials of zinc for the common cold","volume":"133","author":"Desbiens","year":"2000","journal-title":"Ann. Intern. Med."}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987702002050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987702002050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T03:52:32Z","timestamp":1554868352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987702002050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["S0306987702002050"],"URL":"https:\/\/doi.org\/10.1016\/s0306-9877(02)00205-0","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}